Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens

Journal of the American Academy of Dermatology

Volumn 40, Issue 2 I, 1999, Pages 177-186

  Jensen, P ^a   Hansen, S ^a   Moller, B ^a   Leivestad, T ^a   Pfeifer, P ^a   Geiran, O ^a   Fauchald, P ^a   Simonsen, S ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CANCER RISK; CHILD; CONTROLLED STUDY; FEMALE; HEART TRANSPLANTATION; HLA TYPING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; KAPOSI SARCOMA; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MELANOMA; NORWAY; PRIORITY JOURNAL; SKIN CANCER; SQUAMOUS CELL CARCINOMA;

EID: 0033007170     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(99)70185-4     Document Type: Article

References (53)

1. EA Abel Cutaneous manifestations of immunosuppression in organ transplant recipients J Am Acad Dermatol 21 1989 167 179
2. AGR Sheil Skin cancer in renal transplant recipients Transplant Sci 4 1994 42 45
3. MM Hartevelt JNB Bavinck AMM Kootte BJ Vermeer JP Vandenbroucke Incidence of skin cancer after renal transplantation in the Netherlands Transplantation 49 1990 506 509
4. I Blohmé O Larkö Skin lesions in renal transplant patients after 10 to 23 years of immunosuppressive therapy Acta Derm Venereol (Stockh) 70 1990 491 494
5. NJ London SM Farmery EJ Will AM Davison JPA Lodge Risk of neoplasia in renal transplant patients Lancet 346 1995 403 406
6. JM McGregor CM Proby Skin cancer in transplant recipients Lancet 346 1995 964 965
7. JNB Bavinck DR Hardie A Green S Cutmore A MacNaught B O’Sullivan The risk of skin cancer in renal transplant recipients in Queensland, Australia: a follow-up study Transplantation 61 1996 715 721
8. LS Roeger AGR Sheil APS Disney TH Mathew N Amiss Risk factors associated with the development of squamous cell carcinoma in immunosuppressed renal transplant recipients Clin Transpl 6 1992 202 211
9. I Blohmé O Larkö No difference in skin cancer incidence with or without cyclosporine: a 5-year perspective Transplant Proc 24 1992 313
10. MH Bunney EC Benton BB Barr IW Smith JL Anderton JA Hunter The prevalence of skin disorders in renal allograft recipients receiving cyclosporin A compared with those receiving azathioprine Nephrol Dial Transplant 5 1990 379 382
11. SA Gruber K Gillingham RB Sothern E Stephanian AJ Matas DL Dunn De novo cancer in cyclosporine-treated and non-cyclosporine-treated adult primary renal allograft recipients Clin Transplant 8 1994 388 395
12. MT Glover JJ Deeks MJ Raftery J Cunningham IM Leigh Immunosuppression and risk of non-melanoma skin cancer in renal transplant recipients [letter] Lancet 349 1997 398
13. S Euvrard J Kanitakis C Pouteil-Noble G Dureau JL Touraine M Faure Comparative epidemiological study of premalignant and malignant epithelial lesions developing after kidney and heart transplantation J Am Acad Dermatol 33 1995 222 229
14. A Espana P Redondo AL Fernández M Zabala J Herreros R Llorens Skin cancer in heart transplant recipients J Am Acad Dermatol 32 1995 458 465
15. P Jensen OPF Clausen O Geiran S Simonsen A Relbo S Hansen Cutaneous complications in heart transplant recipients in Norway 1983-1993 Acta Derm Venereol (Stockh) 75 1995 400 403
16. JNB Bavinck AMM Kootte FJVD Woude JP Vandenbroucke BJ Vermeer FHJ Claas HLA-A11–associated resistance to skin cancer in renal transplant recipients [letter] N Engl J Med 323 1990 1350
17. JNB Bavinck BJ Vermeer FJVD Woude JP Vandenbroucke GM Schreuder J Thorogood Relation between skin cancer and HLA antigens in renal-transplant recipients N Engl J Med 325 1991 843 848
18. D Czarnecki F Watkins S Leahy D Dyall-Smith A Levis I Nicholson Skin cancers and HLA frequencies in renal transplant recipients Dermatology 185 1992 44 49
19. JNB Bavinck FHJ Claas DR Hardie A Green BJ Vermeer IR Hardie Relation between HLA antigens and skin cancer in renal transplant recipients in Queensland, Australia J Invest Dermatol 108 1997 708 711
20. D Albrectsen T Leivestad P Fauchald A Flatmark G Sødal E Thorsby Results of the national kidney transplantation program in Norway Clin Transpl 1992 207 212
21. T Frøysaker O Geiran H Lindberg E Øvrum S Simonsen K Forfang Two-and-a-half year experience with heart transplantation in Norway Clin Transplant 1 1987 49 51
22. Cancer in Norway 1995 1998 The Cancer Registry of Norway Oslo
23. E Lund Pilot study for the evaluation of completeness of reporting to the Cancer Registry Incidence of cancer in Norway 1978 1981 The Cancer Registry of Norway Oslo
24. S Harvei Evaluation of the completeness of the Norwegian Cancer Registry Annual report 1982, Cancer Registry of Norway 1983 The Cancer Registry of Norway Oslo
25. J Mork S Thoresen H Faye-Lund F Langmark E Glattre A study of the quality of the Cancer Registry of Norway’s data on head and neck cancer for the period 1953-1991 APMIS 103 1995 375 382
26. NE Breslow NE Day Statistical methods in cancer research; vol II. The design and analysis of cohort studies 1987 IARC Lyon
27. D Collett Modelling survival data in medical research 1994 Chapman & Hall London
28. DL Preston JH Lubin DA Pierce ME McConney Epicure. User’s guide 1993 Hirosoft International Corporation Seattle
29. SPSS Advanced Statistics 7.5 1997 SPSS Inc Chicago
30. S-plus. User’s Guide 1997 MathSoft Seattle
31. C Hiesse P Rieu F Kriaa JR Larue C Goupy N Neyrat Malignancy after renal transplantation: analysis of incidence and risk factors in 1700 patients followed during a 25-year period Transplant Proc 29 1997 831 833
32. D Shuttleworth R Marks PJ Griffin JR Salaman Epidermal dysplasia and cyclosporine therapy in renal transplant patients: a comparison with azathioprine Br J Dermatol 120 1989 551 554
33. J Dantal M Hourmant D Cantarovich M Giral G Blancho B Dreno Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens Lancet 351 1998 623 628
34. LJ Swinnen MR Costanzo-Nordin SG Fisher EJ O’Sullivan MR Johnson AL Heroux Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients N Engl J Med 323 1990 1723 1728
35. D Dyall-Smith JB Ross Cutaneous malignancies in renal transplant recipients from Nova Scotia, Canada Australas J Dermatol 36 1995 79 82
36. MT Glover J Bodmer W Bodmer LJ Kennedy J Brown C Navarrete HLA antigen frequencies in renal transplant recipients and non-immunosuppressed patients with non-melanoma skin cancer Eur J Cancer 29A 1993 520 524
37. GN King CM Healy MT Glover JT Kwan DM Williams IM Leigh Increased incidence of dysplastic and malignant lip lesions in renal-transplant recipients N Engl J Med 332 1995 1052 1057
38. SA Birkeland HH Storm LU Lamm L Barlow I Blohmé B Forsberg Cancer risk after renal transplantation in the Nordic countries, 1964-1986 Int J Cancer 60 1995 183 189
39. CH Smith JM McGregor JNWN Barker RW Morris SPA Rigden DM MacDonald Excess melanocytic nevi in children with renal allografts J Am Acad Dermatol 28 1993 51 55
40. J Szepietowski F Wasik T Szepietowski M Wlodarczyk K Sobczak-Radwan W Czyz Excess benign melanocytic naevi in renal transplant recipients Dermatology 194 1997 17 19
41. WY Qunibi Y Barri O Alfurayh K Almeshari B Khan S Taher Kaposi’s sarcoma in renal transplant recipients: a report on 26 cases from a single institution Transplant Proc 25 1993 1402 1405
42. ILL Parola C Masini G Nanni A Diociaiuti N Panocchia D Cerimele Kaposi’s sarcoma in renal-transplant recipients: experience at the Catholic University in Rome, 1988-1996 Dermatology 194 1997 229 233
43. YQ Huang JJ Li MH Kaplan B Poiesz E Katabira WC Zhang Human herpesvirus-like nucleic acid in various forms of Kaposi’s sarcoma Lancet 345 1995 759 761
44. P Jensen YQ Huang JJ Li OPF Clausen AE Friedman-Kien Herpes virus-like DNA (HHV-8) in immunosuppressive therapy-related, HIV-related and classical Kaposi’s sarcoma in Norwegian patients Acta Derm Venereol (Stockh) 78 1998 205 206
45. CG Newstead Assessment of risk of cancer after renal transplantation Lancet 351 1998 610 611
46. I Penn Cancers in cyclosporine-treated vs azathioprine-treated patients Transplant Proc 28 1996 876 878
47. BBB Barr EC Benton K McLaren MH Bunney IW Smith K Blessing Human papilloma virus infection and skin cancer in renal transplant recipients Lancet 1 1989 124 129
48. S Euvrard J Kanitakis C Pouteil-Noble F Disant JF Villaine A Claudy Aggressive squamous cell carcinomas in organ transplant recipients Transplant Proc 27 1995 1767 1768
49. JM McGregor A Farthing T Crook CC Yu EA Dublin DA Levison Posttransplant skin cancer: a possible role for p53 gene mutations but not for oncogenic human papillomaviruses J Am Acad Dermatol 30 1994 701 706
50. D Grossmann DJ Leffell The molecular basis of nonmelanoma skin cancer: new understanding Arch Dermatol 133 1997 1263 1270
51. CA Raskin Apoptosis and cutaneous biology J Am Acad Dermatol 36 1997 885 896
52. JM McGregor CM Proby The role of papillomaviruses in human non-melanoma skin cancer Cancer Surv 26 1996 219 236
53. DC Seukeran CG Newstead WJ Cunliffe The compliance of renal transplant recipients with advice about sun protection measures Br J Dermatol 138 1998 301 303